Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Prepaid Assets (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Prepaid Assets for 4 consecutive years, with $5.8 million as the latest value for Q2 2025.

  • On a quarterly basis, Prepaid Assets fell 8.53% to $5.8 million in Q2 2025 year-over-year; TTM through Jun 2025 was $5.8 million, a 8.53% decrease, with the full-year FY2024 number at $6.6 million, changed N/A from a year prior.
  • Prepaid Assets was $5.8 million for Q2 2025 at Caribou Biosciences, down from $6.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.6 million in Q4 2024 to a low of $671000.0 in Q4 2021.
  • A 3-year average of $4.8 million and a median of $6.0 million in 2024 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: surged 58.63% in 2021, then dropped 8.53% in 2025.
  • Caribou Biosciences' Prepaid Assets stood at $671000.0 in 2021, then surged by 881.97% to $6.6 million in 2024, then fell by 12.31% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Prepaid Assets are $5.8 million (Q2 2025), $6.6 million (Q4 2024), and $6.3 million (Q2 2024).